Complex SCN8A DNA-abnormalities in an individual with therapy resistant absence epilepsy
Bianca Berghuis1, Carolien G F de Kovel2, Loretta van Iterson3
1Stichting Epilepsie Instellingen Nederland SEIN, Zwolle, The Netherlands.
Epilepsy Research
|July 30, 2015
Summary
A rare SCN8A gene deletion and missense variant caused epileptic encephalopathy in a patient. This finding expands understanding of SCN8A mutation mechanisms and associated epilepsy phenotypes.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- SCN8A gene mutations are a rare cause of dominant epileptic encephalopathy.
- This study investigates a unique case of SCN8A-related epilepsy with a mosaic deletion.
Observation:
- A patient presented with absence seizures, behavioral challenges, intellectual disability, and ECG abnormalities.
- Genetic analysis revealed a de novo mosaic deletion of SCN8A exons 2-14 and a rare maternally inherited missense variant.
Findings:
- The identified SCN8A mosaic deletion and missense variant suggest complex mutation mechanisms.
- A concurrent SCN5A variant was also detected in the patient.
Implications:
- This case broadens the known clinical spectrum of SCN8A mutations, including absence epilepsy and developmental regression.
- Potential roles of loss of function, genetic modifiers, and cellular interference in SCN8A-related epilepsy are suggested.
Related Concept Videos
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Biological Causes of Schizophrenia
1.1K
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.1K


